Valeant/Pershing To Allergan: Last Chance To Negotiate
This article was originally published in The Pink Sheet Daily
Executive Summary
After surprising investors by increasing its bid for Allergan for a second time in one week, Valeant and its activist investor partner Pershing Square, urged management to negotiate before a special meeting is convened to oust the company’s board of directors.